B3461114 zhoum55 Wed, 11/04/2026 - 22:40 Vyndamax® / Vyndaqel® Tafamidis (PF-06291826) PHASE I Tue, 02/27/2024 - 12:00 Mon, 05/27/2024 - 12:00 NCT06273839 B3461114 Public Disclosure Synopsis.pdf (90.18 KB) N https://clinicaltrials.gov/study/NCT06273839?term=B3461114&viewType=Card&rank=1 B3461114